Data compiled by Redley Lamar · ChainSifter Intelligence
9Suppliers
8Customers
3Debt Items
16Related Chains
Source-Backed Evidence Depth
CV Sciences, Inc. (CVSI) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
20Total relationships
3Distinct source URLs
9High confidence
0.772Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
CV Sciences, Inc. Suppliers
Ticker
Name
Confidence
Evidence
INVESTOR
INVESTOR
92%
the Company issued and sold to the Investor a secured promissory note in the original principal amount of $1,600,000
FIRST-INSURANCE
FIRST-INSURANCE
90%
In October 2024, the Company entered into a finance agreement with First Insurance in order to fund a portion of its insurance policies for the most recent policy year.
FIRST-INSURANCE-FUNDING
FIRST-INSURANCE-FUNDING
90%
In October 2025, the Company entered into a finance agreement with First Insurance Funding ("First Insurance") in order to fund a portion of its insurance policies for the upcoming policy year.
ONE-CONTRACT-MANUFACTURER
ONE-CONTRACT-MANUFACTURER
90%
In addition, one supplier of shipping and fulfillment services and one contract manufacturer accounted for 16 % each of our outstanding accounts payable as of December 31, 2025.
ONE-PROVIDER-OF-LEGAL-SERVICES
ONE-PROVIDER-OF-LEGAL-SERVICES
90%
One provider of legal services accounted for 41 % and 28 % of our outstanding accounts payable as of December 31, 2025 and 2024, respectively.
ONE-SUPPLIER-OF-SHIPPING-AND-FULFILLMENT-SERVICE
ONE-SUPPLIER-OF-SHIPPING-AND-FULFILLMENT-SERVICE
90%
In addition, one supplier of shipping and fulfillment services and one contract manufacturer accounted for 16 % each of our outstanding accounts payable as of December 31, 2025.
EDXC
Endexx Corporation
72%
Reciprocal relationship from EDXC graph: c., Curaleaf Holdings Inc., CV Sciences, Inc., Elixinol Wellness Ltd., Neuropathix, Inc., Ovation Science Inc., and Zynerba Pharmaceuticals, Inc.; however, th…
Reciprocal relationship from HRMY graph: Reciprocal relationship from CVSI graph: ales for the years ended December 31, 2024 and 2023, respectively. As a result, we do not believe our financial condi…
ales for the years ended December 31, 2024 and 2023, respectively. As a result, we do not believe our financial condition and results of operations is dependent on any one particular major customer. …
Reciprocal relationship from HRMY graph: Reciprocal relationship from CVSI graph: ales for the years ended December 31, 2024 and 2023, respectively. As a result, we do not believe our financial condi…
ales for the years ended December 31, 2024 and 2023, respectively. As a result, we do not believe our financial condition and results of operations is dependent on any one particular major customer. …
CANNAVEST-CORP
CANNAVEST-CORP
62%
r 9, 2010. On July 25, 2013, CannaVest Corp., a Texas corporation (“CannaVest Texas”), merged with CV Sciences, a wholly-owned Delaware subsidiary of CannaVest Texas, to effectuate a change in the Co…
CHARLOTTE-S-WEB-HOLDINGS-INC
CHARLOTTE-S-WEB-HOLDINGS-INC
62%
r the years ended December 31, 2025 and 2024, respectively. As a result, we do not believe our financial condition and results of operations is dependent on any one particular major customer. Our pla…
Reciprocal relationship from CWBHF graph: Reciprocal relationship from CVSI graph: Reciprocal relationship from CWBHF graph: Reciprocal relationship from CVSI graph: Reciprocal relationship from CWBH…
ELEVATED-SOFTGELS-LLC
ELEVATED-SOFTGELS-LLC
62%
r 9, 2010. On July 25, 2013, CannaVest Corp., a Texas corporation (“CannaVest Texas”), merged with CV Sciences, a wholly-owned Delaware subsidiary of CannaVest Texas, to effectuate a change in the Co…
FORECLOSURE-SOLUTIONS-INC
FORECLOSURE-SOLUTIONS-INC
62%
tent application for the technology implemented for CVSI-007 with the U.S. Patent and Trademark Office (“USPTO”). On May 19, 2020, we received a formal notice of issuance from the USPTO for our paten…
INC-MEDTERRA-CBD-INC
INC-MEDTERRA-CBD-INC
62%
r the years ended December 31, 2025 and 2024, respectively. As a result, we do not believe our financial condition and results of operations is dependent on any one particular major customer. Our pla…
CV Sciences, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
CVSI-DEBT
Debt stack $18,000
90%
Market cache reports total debt of $18,000.
CVSI-DEBT-8962
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2023-12-31.
CVSI-DEBT-8961
Warrants outstanding: 10000000
90%
xbrl warrant detail from xbrl 2022-03-30.
CV Sciences, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for CV Sciences, Inc..
CV Sciences, Inc. Ownership
No ownership data on recordNo major institutional ownership relationships found in our database for CV Sciences, Inc..
